including cancer, vaccines, a review of measures regulating the prices of medicinal products, health in the Mediterranean area, and work with health care organisations. Read more…
Tell everyone you meet this week about the organ donor register and save lives
Despite no specific mention of liver disease, this is a huge part of the Horizon 2020 agenda so research projects linking liver disease to diabetes or retinal disease should be considered. Read more....
Now 4028 members from 106 countries
EU Funding

Horizon 2020

Running from 2014 to 2020 with a budget of just over €70 billion, Horizon 2020 is the EU’s new programme for research and innovation which replaces the Seventh Framework Programmes for Research and Technical Development. Horizon 2020 provides major simplification through a single set of rules and will combine all research and innovation funding. For more information please click here.

EU health policy

The EU has played a key role in developing health policy for over 25 years.

The Member States are largely responsible for determining their own health policies but the EU Commission plays a coordinating role through the EU health programme, which has three objectives:

  • fostering good health in an ageing Europe
  • protecting citizens from health threats
  • supporting dynamic health system and new technologies.

The health programme is run by the Directorate General for Health and Consumer Affairs (DG Sanco), which is based in Luxembourg and Brussels. Key areas of work include:

  • Health strategy
  • Ensuring health security
  • Improving health care
  • Risk assessment
  • Taking action against diseases
  • Health in society
  • Fostering good health (prevention)
  • Indicators and data
  • Pharmaceuticals and medical devices

For more on the work of DG Sanco in health see: Health

Key policy areas for liver disease include work on Alcohol, physical inactivity

and obesity

Other areas of work are undertaken by the European Centre for Disease Control (ECDC) in Stockholm, which has responsibility for surveillance and monitoring of communicable diseases, and the European Medicines Agency, which authorizes and monitors the marketing of pharmaceuticals on the EU market.

ECDC: ECDC

EMA: EMA

Health funding in the public health programme

Project funding is allocated under the health strategy programme according to the strategic objectives. Details on projects funded from 2006-13 are here: Health projects

Future health funding 2014-2020

A new health strategy has been agreed by the Member States and Parliament but has not yet entered into force. The first calls for proposals are expected in the spring of 2014. More information will be posted here when it becomes available.

Share